Aktie 906757 SANGUI BIOTECH INTERNATIONAL, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Sangui Biotech International, Inc. OTC Markets

Aktien

906757

US80105B1017

SGBI

Verzögert OTC Markets
Andere Börsenplätze
 20:24:30 17.01.2024 		% 5 Tage % 1. Jan.
0.0015 USD +25.00% Intraday Chart für Sangui Biotech International, Inc. -.--% -48.28%
15.02. Sangui Biotech International, Inc. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 31. Dezember 2023 CI
2023 Sangui Biotech International, Inc. berichtet über die Ergebnisse für das erste Quartal bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Sangui Biotech International, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
Sangui Biotech International, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023
Sangui BioTech International Inc.: Significant increase in sales in the first three quarters of the year - Further reduction of the operating loss
Sangui Biotech International, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
Sangui BioTech International Inc.: Significant increase in sales in the first half of the year - Further reduction of the operating loss
SANGUI BIOTECH INTERNATIONAL INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Sangui Biotech International, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022
Sangui BioTech International Inc.: - Sales of USD 41,029 in first quarter - For the first time, positive quarterly result in the company's history
SANGUI BIOTECH INTERNATIONAL INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Sangui Biotech International, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022
SANGUI BIOTECH INTERNATIONAL INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
Sangui BioTech International Inc.: Increase in sales in the first quarter of 121% - Highest quarterly sales in the company's history
Sangui BioTech International Inc.: Sales of USD 69,190 in fiscal year 2022 - Reduction of the operating loss
SANGUI BIOTECH INTERNATIONAL INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Sangui Biotech International, Inc. Reports Earnings Results for the Full Year Ended June 30, 2022
Sangui Biotech International, Inc. Auditor Raises 'Going Concern' Doubt
Sangui BioTech International Inc.: - Increase in sales in the first nine months of the year - Further reduction of the operating loss
SANGUI BIOTECH INTERNATIONAL INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Sangui Biotech International, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022
Sangui BioTech International Inc.: Significant increase in sales in the first half of the year - Further reduction of the operating loss
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. SBH Aktie
  4. 906757 Aktie
  5. Nachrichten Sangui Biotech International, Inc.
  6. Andere Sprachen